Schorr Melanie, Zhang Xun, Zhao Wenxiu, Abedi Parisa, Lines Kate E, Hedley-Whyte E Tessa, Swearingen Brooke, Klibanski Anne, Miller Karen K, Thakker Rajesh V, Nachtigall Lisa B
AACE Clin Case Rep. 2019 Jun 7;5(5):e276-e281. doi: 10.4158/ACCR-2019-0057. eCollection 2019 Sep-Oct.
To report the first case of 2 synchronous pituitary adenomas, 1 corticotroph and 1 somatotroph, with distinct molecular lineages confirmed by differential hormone and S-100 protein expression.
A case report followed by a literature review are presented.
A 68-year-old woman presented for evaluation of resistant hypertension. Biochemical testing demonstrated adrenocorticotropic hormone (ACTH)-dependent hypercortisolemia and growth hormone (GH) excess. Pituitary magnetic resonance imaging (MRI) revealed a 2 cm left sellar lesion consistent with a pituitary macroadenoma. The patient therefore underwent transsphenoidal surgery for a presumed cosecreting ACTH and GH macroadenoma. Tumor immunohistochemical staining (IHC) was positive for ACTH, but negative for GH. Postoperative biochemical testing confirmed remission from Cushing disease, but the insulin-like growth factor 1 (IGF-1) level remained elevated. Postoperative MRI demonstrated a small right sellar lesion that, in retrospect, had been present on the preoperative MRI. Resection of the right lesion confirmed a GH-secreting adenoma with negative ACTH staining. After the second surgery, the IGF-1 level normalized and blood pressure improved. Further pathologic examination of both surgical specimens demonstrated differential expression of S-100 protein, a folliculostellate cell marker. Reverse transcription polymerase chain reaction of messenger ribonucleic acid from the left sellar lesion was positive for ACTH and negative for GH, confirming the IHC results. Germline mutations in genes known to be associated with pituitary adenoma syndromes (, , , , , , and ) were not detected.
Although the pathogenesis of synchronous pituitary adenomas has not been fully elucidated, this case report suggests that they can have distinct molecular lineages.
报告首例经激素差异表达和S-100蛋白表达证实具有不同分子谱系的2例同步垂体腺瘤,1例促肾上腺皮质激素细胞腺瘤和1例生长激素细胞腺瘤。
本文先进行病例报告,随后进行文献复习。
一名68岁女性因顽固性高血压前来评估。生化检测显示促肾上腺皮质激素(ACTH)依赖性高皮质醇血症和生长激素(GH)过多。垂体磁共振成像(MRI)显示左侧蝶鞍区有一个2 cm的病变,符合垂体大腺瘤。因此,该患者接受了经蝶窦手术,以切除推测为同时分泌ACTH和GH的大腺瘤。肿瘤免疫组化染色(IHC)显示ACTH阳性,但GH阴性。术后生化检测证实库欣病缓解,但胰岛素样生长因子1(IGF-1)水平仍升高。术后MRI显示右侧蝶鞍区有一个小病变,回顾术前MRI也存在该病变。右侧病变切除后证实为分泌GH的腺瘤,ACTH染色阴性。第二次手术后,IGF-1水平恢复正常,血压改善。对两个手术标本进行进一步病理检查,显示S-100蛋白(一种滤泡星状细胞标志物)表达存在差异。对左侧蝶鞍区病变的信使核糖核酸进行逆转录聚合酶链反应,结果显示ACTH阳性,GH阴性,证实了免疫组化结果。未检测到已知与垂体腺瘤综合征相关基因(、、、、、和)的种系突变。
虽然同步垂体腺瘤的发病机制尚未完全阐明,但本病例报告提示它们可能具有不同的分子谱系。